UNKNOWNNA

A Novel Method of Clipped Axillary Lymph Node Localization Post Neoadjuvant Chemotherapy in Breast Cancer Patients .

to determine the feasibility of a novel technique of localization of clipped LN post neoadjuvant chemotherapy

Sponsor

KK Women's and Children's Hospital

Enrollment

15 participants

Sites

1 locations

Start Date

March 2017

Completion

October 2020

Breast Cancer Femaleskin marking of clip axillary lymph node for localisation

Enrollment & Timeline

UNKNOWN

Target enrollment (estimated)

Target N

participants

Sites

locations

Duration

3.6 years

total trial span

Mar 2017Month 113 of 43Oct 2020

100% of trial timeline elapsed

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

retrieval rates of the clipped node using this novel technique

at an average of a year

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Targeted axillary dissection in breast cancer patients with metastatic nodal disease: a prospective study on localization techniques and oncological outcomes.

Lim Geok Hoon, Al Shukairi Aisha Masoud, Lee Yien Sien et al.Gland surgery2025

DOI PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Fetching protocol from ClinicalTrials.gov…

UNKNOWNNA

A Novel Method of Clipped Axillary Lymph Node Localization Post Neoadjuvant Chemotherapy in Breast Cancer Patients .

to determine the feasibility of a novel technique of localization of clipped LN post neoadjuvant chemotherapy

Sponsor

KK Women's and Children's Hospital

Enrollment

15 participants

Sites

1 locations

Start Date

March 2017

Completion

October 2020

Breast Cancer Femaleskin marking of clip axillary lymph node for localisation

Enrollment & Timeline

UNKNOWN

Target enrollment (estimated)

Target N

participants

Sites

locations

Duration

3.6 years

total trial span

Mar 2017Month 113 of 43Oct 2020

100% of trial timeline elapsed

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

retrieval rates of the clipped node using this novel technique

at an average of a year

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Targeted axillary dissection in breast cancer patients with metastatic nodal disease: a prospective study on localization techniques and oncological outcomes.

Lim Geok Hoon, Al Shukairi Aisha Masoud, Lee Yien Sien et al.Gland surgery2025

DOI PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Eligibility

Min Age

21 Years

Max Age

80 Years

Sex

female

Healthy Volunteers

View full criteria

Inclusion Criteria:

* breast cancer patients with involved axillary LN \<3,
* going for neoadjuvant chemotherapy

Exclusion Criteria:

-stage 4 breast cancer patients

A Novel Method of Clipped Axillary Lymph Node Localization Post Neoadjuvant Chemotherapy in Breast Cancer Patients .

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

A Novel Method of Clipped Axillary Lymph Node Localization Post Neoadjuvant Chemotherapy in Breast Cancer Patients .

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Eligibility

Trial Sites (1)